These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4597988)

  • 1. In vitro interference between low and high leukaemogenic variants of Rauscher virus.
    Boyd RE; Youn JK; Barski G
    Int J Cancer; 1973 Jan; 11(1):224-30. PubMed ID: 4597988
    [No Abstract]   [Full Text] [Related]  

  • 2. [A comparative study of "in vitro" infectivity and "in vivo" leukemogenicity of Rauscher leukemia virus variants (author's transl)].
    Barbieri D; Barski G
    Ann Microbiol (Paris); 1973 Mar; 124(2):243-60. PubMed ID: 4583942
    [No Abstract]   [Full Text] [Related]  

  • 3. Presence of antibody against mouse fetal antigen in the sera from C57BL-6 mice immunized with Rauscher leukemia.
    Ishimoto A; Ito Y
    Cancer Res; 1972 Nov; 32(11):2332-7. PubMed ID: 4343227
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-leukemogenic variants of Rauscher leukemia virus obtained in long-term cultures at supra-optimal temperature.
    Barski G; Barbieri D; Youn JK; Hue G
    Int J Cancer; 1973 Jul; 12(1):55-65. PubMed ID: 4597863
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interaction of the Sindbis virus and Rauscher and Friend leukoviruses in primary cultures and subcultures of mouse fibroblasts in the early stages of persistence].
    Pogodina VV; Kiseleva LL; Fokina GI; Korolev MB; Sensiuta NB
    Vopr Virusol; 1977; (1):44-50. PubMed ID: 333760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High and low leukemogenic variants of Rauscher virus having a comparable infectivity in vitro.
    Barski G
    Bibl Haematol; 1970; (36):323-6. PubMed ID: 4376368
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro assessment of cellular immunity to Rauscher leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1973 Sep; 111(3):657-60. PubMed ID: 4741293
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of Rauscher leukaemia virus on the immune system in susceptible and resistant mouse strains.
    Tóth FD; Karsai T; Váczi L
    Acta Microbiol Acad Sci Hung; 1971; 18(4):271-8. PubMed ID: 4136204
    [No Abstract]   [Full Text] [Related]  

  • 9. [Persistence of M. arthritidis and the Rauscher leukemia virus in a mixed Mycoplasma-viral infection in mice].
    Rakovskaia IV
    Vestn Akad Med Nauk SSSR; 1985; (3):32-8. PubMed ID: 3993191
    [No Abstract]   [Full Text] [Related]  

  • 10. Virion and non-virion murine leukemia membrane antigens: analysis with virus-absorbed antisera.
    Moroni C; Robert-Guroff M; Martin D
    Intervirology; 1974; 3(5-6):292-304. PubMed ID: 4443190
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of interferon treatment on the tumour-specific antibody response of BALB-c mice infected with Rauscher virus.
    Tóth FD; Váczi L; Berencsi C
    Acta Microbiol Acad Sci Hung; 1971; 18(2):109-12. PubMed ID: 4337368
    [No Abstract]   [Full Text] [Related]  

  • 12. Interferon and antibody production in inbred mice infected with the Rauscher virus.
    Tóth FD; Váczi L; Berencsi C
    Acta Microbiol Acad Sci Hung; 1971; 18(1):23-7. PubMed ID: 4335323
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence against the neoplastic nature of virus-induced erythroblastosis in mice.
    Bentvelzen P
    Eur J Cancer (1965); 1972 Oct; 8(5):583-4. PubMed ID: 4651791
    [No Abstract]   [Full Text] [Related]  

  • 14. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC; Shiu G; Rodrigues D; Herberman RB
    Cancer Res; 1974 Jul; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic control of antinuclear antibodies in mice infected with Rauscher leukemia virus.
    Varet B; Cannat A; Gisselbrecht S
    Cancer Res; 1977 Apr; 37(4):1115-8. PubMed ID: 300277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group- and type-specific antigens in mouse leukaemia induced by Friend, Mazurenko and Rauscher viruses.
    Mazurenko NP; Gurtsevich VE
    Neoplasma; 1972; 19(4):277-82. PubMed ID: 4341019
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antilymphocytic humoral autoimmune response of mice with developing Rauscher leukemia directed against group-specific retrovirus antigens].
    Ter-Grigorov VS; Graf IA; Pivnik AV; Etkin AF; Moskovkina OIa
    Eksp Onkol; 1987; 9(6):48-51. PubMed ID: 3325268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytotoxic and blocking antibodies in the sera and eluates from spleen cells of mice with Rauscher leukemia following a different course].
    Ter-Grigorov VS; Dzagurov SG; Shevelev BI
    Biull Eksp Biol Med; 1975 Feb; 79(2):76-80. PubMed ID: 48386
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppressive effect of immunization with mouse fetal antigens on growth of cells infected with Rauscher leukemia virus and plasma-cell tumors.
    Hanna MG; Tennant RW; Coggin JH
    Proc Natl Acad Sci U S A; 1971 Aug; 68(8):1748-52. PubMed ID: 4942913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of RBL-5 leukemia cells cultivated in vitro.
    Liu WT; Rogers MJ; Law LL; Chang KS
    J Natl Cancer Inst; 1977 Jun; 58(6):1661-4. PubMed ID: 864745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.